Founders Fund V Management, LLC

In its 13F for Q3 2024 (holdings as of September 30, 2024, filed February 14, 2025), Founders Fund V Management, LLC reported 4 stock positions worth $572 thousand. Its top holding was Cyclo Therapeutics (CYTH) at 66.3% of the portfolio, followed by Unity Biotechnology (UNBX, 12.6%) and Rigetti Computing (RGTI, 12.1%). Its holdings were unchanged from Q2 2024.

Most Recent 13F
Q4 2025
Location
SAN FRANCISCO, CA
CIK
0001697733
Portfolio Value
$572K (Q3 2024)
SEC Filing
0001085146-25-001673 ↗ filed Feb 14, 2025

Holdings Value

0$1.0M$2.0M$3.0M Q1 2024: $1.1M Q1 2024 Q2 2024: $846K Q2 2024 Q3 2024: $572K $572K Q3 2024 Q4 2024: $1.7M Q4 2024 Q1 2025: $1.1M Q1 2025 Q2 2025: $1.4M Q2 2025 Q3 2025: $2.9M Q3 2025 Q4 2025: $2.2M Q4 2025

Holdings 4 stocks · $572K
CYTH Cyclo Therapeutics Inc. 66.35% 480,708 $379K No change
UNBX Unity Biotechnology Inc. 12.64% 49,172 $72K No change
RGTI Rigetti Computing Inc. 12.14% 88,621 $69K No change
NTBLQ Notable Labs Ltd. 8.87% 117,924 $51K No change

Portfolio Sells Q2 2024 → Q3 2024
None this quarter.

Portfolio Buys Q2 2024 → Q3 2024
None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q4 2025 2$2.2MRGTI, RFL
Q3 2025 2$2.9MRGTI, RFL
Q2 2025 4$1.4MRGTI, RFL, UNBX, PRCH
Q1 2025 3$1.1MRGTI, RFL, UNBX
Q4 2024 3$1.7MRGTI, CYTH, UNBX
Q3 2024Amended 4$572KCYTH, UNBX, RGTI, NTBLQ
Q2 2024 4$846KCYTH, RGTI, NTBLQ, UNBX
Q1 2024 4$1.1MCYTH, NVMI, RGTI, UNBX